Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore when bonds may be preferred over the Sp500 in retirement and how a cautious mix can protect assets while supporting withdrawals. This intro covers key timing considerations and conservative principles.
23,766 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
With a funding deadlock gripping the federal government, Trump’s border czar says ICE could be deployed to airport sc...
A new Ripple survey shows banks leaning into digital assets, with stablecoins leading cash-flow efficiency. For XRP, ...
Disney faces a pivotal year as it retools streaming and parks. This disney stock price prediction outlines scenarios ...
Tesla reports its first European sales uptick in over a year, a modest but meaningful turn that investors are watchin...
Qualcomm is navigating a tough start to 2026. A memory crunch, potential shifts with Apple, and a large buyback are m...
Raymond James raises its price target on Phillips 66 to $205, citing a peak in refining margins and geopolitical tail...
Two private school boys probation decision follows a case in which AI was used to forge 350 nude images of classmates...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
Two retail powerhouses deliver contrasting plays for 2026: Amazon bets big on AI and cloud infrastructure, while Walm...
Tether is moving deeper into regulatory oversight by enlisting KPMG for its first major audit, signaling a new era fo...
Gas prices are edging higher as global tensions affect crude markets. The news price tracker shows the national avera...